KIC
TNDM icon

Kensington Investment Counsel’s Tandem Diabetes Care TNDM Stock Holding History

Kensington Investment Counsel’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,403
Closed -$2.17M – 90
2021
Q4 		$2.17M Buy
+14,403
New +$1.94M 1.26% 32
2021
Q2 		$1.23M Buy
12,611
+315
+3% +$28.1K 0.84% 59
2021
Q1 		$1.08M Buy
12,296
+1,058
+9% +$98.3K 0.82% 60
2020
Q4 		$1.07M Buy
+11,238
New +$1.16M 0.89% 57

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Kensington Investment Counsel's TNDM Position: Q1 2022 in Review

Kensington Investment Counsel sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 14,403 shares — an estimated $2.17M sold.

Kensington Investment Counsel first reported a position in TNDM in Q4 2020 and held it in 4 quarters. The position peaked at $2.17M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Kensington Investment Counsel reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Kensington Investment Counsel sold 14,403 Tandem Diabetes Care shares in Q1 2022, an estimated $2.17M.
  • Kensington Investment Counsel first reported a position in Tandem Diabetes Care in Q4 2020 and held it in 4 quarters.
  • Kensington Investment Counsel's Tandem Diabetes Care position peaked at $2.17M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Kensington Investment Counsel's 13F filing for Q1 2022, filed 13 May 2022.